Abstract: Embodiments of the present invention propose a D2D communications method, apparatus, and system. In the solution, a D2D SPS available period in which a first terminal is capable of using a D2D SPS resource is greater than one SC period. Therefore, in the D2D SPS available period, the first terminal needs to determine the D2D SPS resource only one time, and a second terminal also needs to decode SCI only one time to determine the D2D SPS resource. In this way, the first terminal does not need to determine a D2D SPS resource in each SC period, and the second terminal also does not need to decode SCI in each SC period to determine the D2D SPS resource. Therefore, D2D communication efficiency is improved.

Abstract: A service data transmission method, a first communications node and a base station are disclosed. In an embodiment a method includes obtaining, by a first communications node, transmission carrier frequency configuration information of a first service type, wherein the transmission carrier frequency configuration information of the first service type includes at least one first transmission carrier frequency identifier, obtaining, by the first communications node, first service data and a first identifier, wherein the first identifier indicates that the first service data belong to the first service type, determining, by the first communications node based on the first identifier and the first transmission carrier frequency identifier, a first transmission carrier frequency corresponding to the first transmission carrier frequency identifier and transmitting, by the first communications node, the first service data on the first transmission carrier frequency.

Abstract: A relay determining method and apparatus are provided. The method includes: sending a first message to a second terminal, where the first message is used to instruct the second terminal to determine a type of the second terminal based on the first message; the first-type terminal sends first measurement information; or the second-type terminal receives first measurement information sent by a first-type terminal, determines quality of a first link between the first-type terminal and the second-type terminal, and sends the quality of the first link to the first terminal; receiving the quality of the first link sent by the second-type terminal; determining a mapping relationship between the first-type terminal and the second-type terminal based on the quality of the first link; and sending the mapping relationship to terminals corresponding to the mapping relationship. In embodiments of the present invention, information transmission reliability can be improved.

Abstract: The invention relates to synthetic liver-specific promoters and expression constructs for producing polypeptides and functional nucleic acids in the liver of a subject. The invention further relates to Factor VIII proteins containing modifications in the amino acid sequence of the Factor VIII protein, as well as nucleic acid constructs encoding the Factor VIII proteins and methods of using these compositions to treat a bleeding disorder.

Abstract: A process for separate removal and recovery of heavy metals from industrial wastewater is provided. The wastewater to be treated flows through adsorbents after filtration and adjustment of a pH to about 3 to 7 to obtain the adsorbents which have adsorbed corresponding heavy-metal ions, which are then eluted from the corresponding adsorbents using an acidic solution such that eluates containing the corresponding heavy-metal ions are obtained.

Abstract: Systems, methods, and computer-readable media for managing or classifying movement states of an electronic device are provided that may utilize communications circuitry data from one or more communications circuitries when determining a current or future movement state of an electronic device.

Abstract: The invention relates to synthetic polynucleotides encoding fukutin related protein (FKRP). The invention further relates to nucleic acid constructs comprising the synthetic polynucleotides and methods of using these synthetic polynucleotides to treat dystroglycanopathy disorders.

Abstract: Embodiments of the present invention disclose a method for data transmission in a wireless network, an apparatus, and a system. The method for data transmission includes: determining, by a terminal device, first configuration information; and if the terminal device determines that type-1 data and type-2 data need to be transmitted at a same time, allocating, by the terminal device, a first transmit power for first data based on the first configuration information. In this case, transmission performance of a system in a high-density service scenario is improved, while transmission quality of important data is ensured.

Abstract: A data verification method is provided. Fingerprint information of N (N being an integer greater than 1) slices of to-be-sent data of a second device is received, the fingerprint information including first fingerprint information corresponding to an ith (i being an integer greater than 1) slice of the to-be-sent data and second fingerprint information corresponding to an (i?1)th slice of the to-be-sent data. The first fingerprint information is based on updating, by using the ith slice of the to-be-sent data, the second fingerprint information. An ith slice of data is received from the second device. The received second fingerprint information is updated by using the ith slice of data, to obtain third fingerprint information. Data verification failure indication information is transmitted to the second device in response to the third fingerprint information not matching the received first fingerprint information.

Abstract: A method for a multi-screen interaction system for an augmented reality scene, information processing devices, and a non-transitory computer-readable storage medium are provided. In the method, a resource object of the augmented reality scene, in which an augmented reality marker is embedded, is displayed. An augmented reality effect play message is received from a second device of the multi-screen interaction system for the augmented reality scene through a communication connection. An augmented reality resource associated with the augmented reality effect play message is displayed in response to the received augmented reality effect play message.

Abstract: A vehicle-to-entity (V2X) communication method, device, and system, the method including obtaining, by a terminal, a correspondence between a priority of a pedestrian-to-entity (P2X) service data packet and a V2X communication parameter value range, where the V2X communication parameter comprises at least one of a modulation and coding scheme (MCS), a quantity of transmissions, a transmit power, or a quantity of occupied resource blocks (RBs), determining, by the terminal, according to the priority of the P2X service data packet and the correspondence, a V2X communication parameter value range corresponding to the priority of the P2X service data packet, selecting, by the terminal, a V2X communication parameter value from the determined V2X communication parameter value range, and transmitting, by the terminal, the P2X service data packet on a radio resource according to the selected V2X communication parameter value.

Abstract: The invention relates to synthetic polynucleotides encoding fukutin related protein (FKRP). The invention further relates to nucleic acid constructs comprising the synthetic polynucleotides and methods of using these synthetic polynucleotides to treat dystroglycanopathy disorders.

Abstract: The present disclosure provides a data sending method, a base station, and a communications node. The sending method includes: sending, by a first communications node, first request information to a base station, where the first request information is used to request first information from the base station, and the first information is used to indicate authorization of a first resource; determining, by the first communications node, second information, where the second information is used to indicate authorization of a second resource, and the second resource is selected by the first communications node from a preset resource. The first information is allocated by the base station, the second information is determined by the communications node, and the communications node flexibly selects information for communication between communications nodes. In this way, both reliability and flexibility of the communication between the communications nodes are improved.

Abstract: This invention belongs to the field of biomedicine and relates to use of Bcl-xL inhibitor and oncolytic virus in the preparation of an anti-tumor drug. The present invention firstly discovers that the Bcl-xL inhibitor can be used as an anti-tumor synergist for oncolytic virus. The present invention also relates to a pharmaceutical composition comprising Bcl-xL inhibitor and oncolytic virus, a pharmaceutical kit comprising Bcl-xL inhibitor and oncolytic virus, and use of Bcl-xL inhibitor and oncolytic virus for treating tumors, especially, tumors that are not sensitive to the oncolytic virus.

Abstract: Described herein is use of a Caspase activator and an oncolytic virus in the preparation of an anti-tumor drug. As described, Caspase activator can enhance the anti-tumor effect of oncolytic virus, and the combination of Caspase activator and oncolytic virus produces a significant synergistic anti-tumor effect, and demonstrates an effective therapy for the treatment of tumors that are less sensitive to other pharmaceutical treatments.

Abstract: The present invention belongs to the field of biomedicine and relates to use of VCP (valosin-containing protein, VCP) inhibitor and oncolytic virus in the preparation of an anti-tumor drug. The present invention firstly discovers that VCP inhibitor can be used in the preparation of an anti-tumor synergist for oncolytic virus. Meanwhile, the present invention relates to a pharmaceutical composition comprising VCP inhibitor and oncolytic virus, a pharmaceutical kit comprising VCP inhibitor and oncolytic virus, and use of VCP inhibitor and oncolytic virus for treating tumor, especially a tumor that is not sensitive to oncolytic virus. The present invention also relates to an anti-tumor administration system, characterized in that, comprising oncolytic virus and a reagent for detecting the expression level of VCP.

Abstract: This disclosure relates to the field of data transmission technologies, and in particular, to a semi-persistent transmission method and apparatus. The semi-persistent transmission method includes: obtaining, by user equipment UE, a semi-persistent transmission resource; determining, by the UE, a logical channel having a correspondence with the semi-persistent transmission resource; and transmitting, by the UE on the semi-persistent transmission resource, data in the logical channel having the correspondence with the semi-persistent transmission resource. The semi-persistent transmission method and apparatus in embodiments of the present invention can support scheduled transmission of various semi-persistent service data.

Abstract: Embodiments of the present disclosure provide a data transmission method and apparatus. The method includes: receiving, by user equipment UE, first synchronization source configuration information on a first carrier; determining, a first synchronization source based on the first synchronization source configuration information; determining that synchronization with the first synchronization source fails; determining a second synchronization source and a transmission resource; and transmitting data on a second carrier using the determined transmission resource and based on the second synchronization source, where the first synchronization source is used to provide the UE with a synchronization clock required for transmitting the data on the second carrier, and a frequency of the first carrier is different from a frequency of the second carrier.

Abstract: The invention relates to synthetic liver-specific promoters and expression constructs for producing polypeptides and functional nucleic acids in the liver of a subject. The invention further relates to Factor VIII proteins containing modifications in the amino acid sequence of the Factor VIII protein, as well as nucleic acid constructs encoding the Factor VIII proteins and methods of using these compositions to treat a bleeding disorder.

Abstract: Embodiments of the present invention provide a V2X message sending method, apparatus, and system, and relate to the field of Internet of Vehicles. The method includes: obtaining, by a terminal, first configuration information, where the first configuration information is used for determining a first transmission resource pool; determining the first transmission resource pool based on the first configuration information; selecting a first transmission resource from the first transmission resource pool in a first transmission resource obtaining manner when a preset condition is met; and sending a V2X message by using the first transmission resource.